Tapi Nl Bv, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is VALBENAZINE TOSYLATE, with a corresponding US DMF Number 35290.
Remarkably, this DMF maintains an Active status since its submission on October 28, 2020, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 02, 2021, and payment made on October 09, 2020, indicating their dedication to facilitating drug approvals, Categorized as Type II